Page 192 - Read Online
P. 192

Padarti et al. Vessel Plus 2018;2:21  I  http://dx.doi.org/10.20517/2574-1209.2018.34                                                 Page 19 of 23

               44.  Li X, Zhang R, Draheim KM, Liu W, Calderwood DA, Boggon TJ. Structural basis for small G protein effector interaction of Ras-
                   related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1). J Biol Chem 2012;287:22317-27.
               45.  Fisher OS, Boggon TJ. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell
                   Mol Life Sci 2014;71:1881-92.
               46.  Faurobert E, Albiges-Rizo C. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.
                   FEBS J. 2010;277:1084-96.
               47.  Francalanci F, Avolio M, De Luca E, Longo D, Menchise V, Guazzi P, et al. Structural and functional differences between KRIT1A and
                   KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp Cell Res 2009;315:285-303.
               48.  Beraud-Dufour S, Gautier R, Albiges-Rizo C, Chardin P, Faurobert E. Krit 1 interactions with microtubules and membranes are
                   regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J 2007;274:5518-32.
               49.  Goult BT, Bate N, Anthis NJ, Wegener KL, Gingras AR, Patel B, Barsukov IL, Campbell ID, Roberts GC, Critchley DR. The structure
                   of an interdomain complex that regulates talin activity. J Biol Chem 2009;284:15097-106.
               50.  Goult BT, Bouaouina M, Elliott PR, Bate N, Patel B, Gingras AR, Grossmann JG, Roberts GC, Calderwood DA, Critchley DR,
                   Barsukov IL. Structure of a double ubiquitin-like domain in the talin head: a role in integrin activation. EMBO J 2010;29:1069-80.
               51.  Pecqueur L, Duellberg C, Dreier B, Jiang Q, Wang C, Plückthun A, Surrey T, Gigant B, Knossow M. A designed ankyrin repeat protein
                   selected to bind to tubulin caps the microtubule plus end. Proc Natl Acad Sci U S A 2012;109:12011-6.
               52.  Zhang R, Li X, Boggon TJ. Structural analysis of the KRIT1 ankyrin repeat and FERM domains reveals a conformationally stable
                   ARD-FERM interface. J Struct Biol 2015;192:449-56.
               53.  Bessman MJ, Frick DN, O’Handley SF. The MutT proteins or “Nudix” hydrolases, a family of versatile, widely distributed,
                   “housecleaning” enzymes. J Biol Chem 1996;271:25059-62.
               54.  Liu W, Draheim KM, Zhang R, Calderwood DA, Boggon TJ. Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin
                   activation. Mol Cell 2013;49:719-29.
               55.  Petit N, Blecon A, Denier C, Tournier-Lasserve E. Patterns of expression of the three cerebral cavernous malformation (CCM) genes
                   during embryonic and postnatal brain development. Gene Expr Patterns 2006;6:495-503.
               56.  Seker A, Pricola KL, Guclu B, Ozturk AK, Louvi A, Gunel M. CCM2 expression parallels that of CCM1. Stroke 2006;37:518-23.
               57.  Zhang J, Carr C, Badr A. The cardiovascular triad of dysfunctional angiogenesis. Transl Stroke Res 2011;2:339-45.
               58.  Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular
                   integrity. J Exp Med 2010;207:881-96.
               59.  Fisher OS, Liu W, Zhang R, Stiegler AL, Ghedia S, Weber JL, Boggon TJ. Structural basis for the disruption of the cerebral cavernous
                   malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations. J Biol Chem
                   2015;290:2842-53.
               60.  Scimone C, Bramanti P, Ruggeri A, Donato L, Alafaci C, Crisafulli C, Mucciardi M, Rinaldi C, Sidoti A, D’Angelo R. CCM3/
                   SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study. BMC
                   Med Genet 2016;17:74.
               61.  Kean MJ, Ceccarelli DF, Goudreault M, Sanches M, Tate S, Larsen B, Gibson LC, Derry WB, Scott IC, Pelletier L, Baillie GS, Sicheri F,
                   Gingras AC. Structure-function analysis of core STRIPAK Proteins: a signaling complex implicated in Golgi polarization. J Biol Chem.
                   2011;286(28):25065-75.
               62.  Dibble CF, Horst JA, Malone MH, Park K, Temple B, Cheeseman H, Barbaro JR, Johnson GL, Bencharit S. Defining the functional
                   domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate. PLoS One. 2010;5:e11740.
               63.  Li X, Zhang R, Zhang H, He Y, Ji W, Min W, Boggon TJ. Crystal structure of CCM3, a cerebral cavernous malformation protein critical
                   for vascular integrity. J Biol Chem. 2010;285:24099-107.
               64.  Lant B, Yu B, Goudreault M, Holmyard D, Knight JD, Xu P, Zhao L, Chin K, Wallace E, Zhen M, Gingras AC, Derry WB. CCM-3/
                   STRIPAK promotes seamless tube extension through endocytic recycling. Nat Commun 2015;6:6449.
               65.  Rehain-Bell K, Love A, Werner ME, MacLeod I, Yates JR, 3rd, Maddox AS. A Sterile 20 Family Kinase and Its Co-factor CCM-3
                   Regulate Contractile Ring Proteins on Germline Intercellular Bridges. Curr Biol 2017;27:860-7.
               66.  Berman JR, Kenyon C. Germ-cell loss extends C. elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone
                   signaling. Cell 2006;124:1055-68.
               67.  Guzeloglu-Kayisli O, Amankulor NM, Voorhees J, Luleci G, Lifton RP, Gunel M. KRIT1/cerebral cavernous malformation 1 protein
                   localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 2004;54:943-9;
                   discussion 9.
               68.  Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC. Novel insights regarding the pathogenesis of cerebral cavernous
                   malformation (CCM). American Journal of Human Genetics 2001;69:178.
               69.  Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing
                   protein encoded by a gene mapping to 7q21-22. Oncogene 1997;15:1043-9.
               70.  Frische EW, Zwartkruis FJ. Rap1, a mercenary among the Ras-like GTPases. Dev Biol 2010;340:1-9.
               71.  Liu JJ, Stockton RA, Gingras AR, Ablooglu AJ, Han J, Bobkov AA, Ginsberg MH. A mechanism of Rap1-induced stabilization of
                   endothelial cell--cell junctions. Mol Biol Cell 2011;22:2509-19.
               72.  Liu H, Rigamonti D, Badr A, Zhang J. Ccm1 regulates microvascular morphogenesis during angiogenesis. J Vasc Res 2011;48:130-40.
               73.  Lakshmikanthan S, Sobczak M, Chun C, Henschel A, Dargatz J, Ramchandran R, Chrzanowska-Wodnicka M. Rap1 promotes VEGFR2
                   activation and angiogenesis by a mechanism involving integrin alphavbeta(3). Blood 2011;118:2015-26.
   187   188   189   190   191   192   193   194   195   196   197